Tao Shen

Kunming University of Science and Technology

Also affiliated with Shandong University of Traditional Chinese Medicine, Guiyang Medical University, Shandong University, Jinan University, North China University of Water Resources and Electric Power, Chinese Academy of Medical Sciences & Peking Union Medical College, Washington University in St. Louis, Sichuan University, Kunming Medical University, Wuhan University, First People's Hospital of Yunnan Province, Zhongda Hospital Southeast University, Affiliated Hospital of Guizhou Medical University, Women's Hospital, School of Medicine, Zhejiang University, Renmin Hospital of Wuhan University, Hunan Provincial People's Hospital, University of Oklahoma Health Sciences Center

Agricultural and Biological SciencesMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations”.

Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations

Annals of Oncology(2020)10.1016/j.annonc.2020.10.599

N/A

0.829DataRank · unranked

251 citations

Tao Shen, S. Terzyan, X. Liu, Xueqing Hu, Khadijah Patel +8 more

The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib

npj Precision Oncology(2021)10.1038/s41698-021-00188-x

N/A

0.587DataRank · unranked

49 citations

Xueqing Hu, Xuan Liu, Vivek Subbiah, Blaine H. M. Mooers, Jie Wu +1 more

A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression

Cancer Letters(2023)10.1016/j.canlet.2023.216333

N/A

0.360DataRank · unranked

10 citations

Guoliang Zhang, Zheng Wang, Dayong Zheng, Mohit Hulsurkar, Michael Bakhoum +5 more

MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade

Nature Communications(2022)10.1038/s41467-021-27921-1

N/A

0DataRank · unranked

46 citations

Dong Han, Qinbo Cai, Tao Shen, Bingning Dong, Michael T. Lewis +8 more

Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer

npj Precision Oncology(2024)10.1038/s41698-024-00563-4

N/A

0DataRank · unranked

25 citations

Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven I. Sherman +8 more

Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model

Cancer Letters(2025)10.1016/j.canlet.2025.217444

N/A

0DataRank · unranked

3 citations

Mohamed A. Gouda, Shriya Pandey, Neeraj Chauhan, Tao Shen, Xueqing Hu +5 more

Iron chelation inhibits mTORC1 signaling involving activation of AMPK and REDD1/Bnip3 pathways

Oncogene(2020)10.1038/s41388-020-1366-5

N/A

0DataRank · unranked

43 citations

Hongyu Zhou, Wang Liu, Tao Shen, Yan Luo, Shile Huang +1 more

Oncogenic Activation of AKT by MAPK6

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.23.309518

N/A

0DataRank · unranked

0 citations

Wei Wang, Bingning Dong, Wolong Zhou, Tao Shen, David D. Moore +3 more